Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Follow-On Study to Cingal 13-01 to Evaluate the Safety of a Repeat Injection of Cross-Linked Sodium Hyaluronate Combined With Triamcinolone Hexacetonide to Provide Symptomatic Relief of Osteoarthritis of the Knee

NCT02381652 is registered in ClinicalTrials.gov with Anika Therapeutics, Inc. as lead sponsor.

NCT NCT02381652
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02381652 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Follow-On Study to Cingal 13-01 to Evaluate the Safety of a Repeat Injection of Cross-Linked Sodium Hyaluronate Combined With Triamcinolone Hexacetonide to Provide Symptomatic Relief of Osteoarthritis of the Knee
Lead sponsor
Anika Therapeutics, Inc.
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2015
Completion date
May 31, 2015
Enrollment
242 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis of the knee